Clinical Trials Update: Nov. 21, 2006
Insomnia Fungal Infections Primary Immunodeficiency Disorders
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
If you are ages 65 to 85 and having problems falling asleep or staying asleep, you may qualify for this clinical study of an investigational medication to treat insomnia. Participants will receive all study-related care and evaluations at no cost, and compensation is available for time and travel.
The research site is in Pinellas Park, Fla.
This clinical study will evaluate an investigational medication for toenail fungus. Participants ages 16-75 will receive all study-related exams and investigational medication, and compensation up to $375 is available for time and travel.
The research site is in Lakewood, Wash.
Primary Immunodeficiency Disorders
This study is for people with primary immunodeficiency disorder (PIDD). Volunteers 2-70 years old with documented PIDD requiring immune globulin replacement may qualify. Participants may not have an acute infection at the time of screening, may not be pregnant, breastfeeding, or intend to become pregnant during the study, and may not have a history of anaphylactic or severe systemic response to immune globulin preparations.
The research site is in Great Neck, NY.
Copyright 2006 Thomson CenterWatch. All rights reserved.